BRCA1 and breast neoplasm: In addition, cytoplasmic FIH appears as a prognostic marker in BRCA1 breast tumours conferring a shorter relapse-free and overall survival, despite its association with a lower grade, whereas no such differences are seen for nuclear FIH.